Search Results 211-220 of 16749 for alt

1. Alisertib in Treating Patients With Myelofibrosis or Relapsed or Refractory Acute Megakaryoblastic Leukemia - Mayo Clinic

   AMKL PATIENTS: Aspartate aminotransferase (AST)/alanine aminotransferase (ALT) ≤ 2.5 x ULN. AMKL PATIENTS: Creatinine < 1.5 x ULN or calculated creatinine ...

2. Study Of HPN536 In Patients With Advanced Cancers Associated With Mesothelin Expression - Mayo Clinic

   Aspartate and alanine transaminase (AST and ALT) ≤ 2.5 x ULN or AST/ALT ≤ 5 x ULN for patients with liver metastases. Serum albumin ≥ 30 mg/mL. Exclusion ...

3. Atezolizumab, Pemetrexed Disodium, Cisplatin, and Surgery With or Without Radiation Therapy in Treating Patients With Stage I-III Pleural Malignant Mesothelioma - Mayo Clinic

   ... (ALT) =< 3 x ULN (within 28 days prior to step 1 registration) - No other prior malignancy is allowed except for the following: adequately treated basal cell ...

4. Safety and Efficacy of Selonsertib, GS-0976, GS-9674, and Combinations in Participants With Bridging Fibrosis or Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH) - Mayo Clinic

   Alanine aminotransferase (ALT) < 5 x Upper Limits of Normal (ULN); Platelet count ≥ 125,000/μL. Exclusion Criteria: Prior history of decompensated liver ...

5. Study Using Chromogranin A As Surveillance Biomarker In Patients With CARcinoids - Mayo Clinic

   ... (ALT) 1.5 x ULN; Severe liver dysfunction in the presence of liver metastasis defined by AST and ALT over 5 x ULN and total bilirubin over 1.5 x ULN). Severe ...

6. Chest pain - Doctors and departments - Mayo Clinic

   Pain in the chest has many possible causes — and some of them are serious. Here's why it's so important to see your health care provider about chest pain.

7. A Study To Find Out Whether BI 1015550 Improves Lung Function In People With Idiopathic Pulmonary Fibrosis (IPF) - Mayo Clinic

   transplant list is allowed. 8. Aspartate amino transferase (AST) or Alanine amino transferase (ALT) > 2.5 x upper limit of normal (ULN) or total Bilirubin ...

8. A Trial of the FMS-like Tyrosine Kinase 3 (FLT3) Inhibitor Gilteritinib Administered as Maintenance Therapy Following Allogeneic Transplant for Patients With FLT3/Internal Tandem Duplication (ITD) Acute Myeloid Leukemia (AML) - Mayo Clinic

   Serum AST and/or alanine aminotransferase (ALT) < 3 x institutional upper limit of normal (ULN). Participant has left ventricular ejection fraction (LVEF) ...

9. Assessing the Role of "Statin" Therapy and Perioperative Inflammatory Response in Patients Undergoing Major Orthopedic Surgery - Mayo Clinic

   perioperative statin group. Exclusion Criteria: pregnancy; lactating females; oral or parenteral corticosteroid use in the past 30 days; elevation of AST or ALT ...

10. Liver transplant - Doctors & Departments - Mayo Clinic

    Joo DJ, et al. Bioartificial liver support for acute liver failure. Annals of Liver Transplantation. 2025; doi:10.52604/alt.25.0004. Taner T, et al. Summary of ...